| CD30 expression in peripheral T-cell lymphomas E Sabattini, M Pizzi, V Tabanelli, P Baldin, CS Sacchetti, C Agostinelli, ... Haematologica 98 (8), e81-e82, 2013 | 158 | 2013 |
| Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ... Annals of Oncology 29 (12), 2363-2370, 2018 | 113 | 2018 |
| Blastic plasmacytoid dendritic cell neoplasm: state of the art and prospects MR Sapienza, A Pileri, E Derenzini, F Melle, G Motta, S Fiori, A Calleri, ... Cancers 11 (5), 595, 2019 | 96 | 2019 |
| Randomized trial comparing R-CHOP versus high-dose sequential chemotherapy in high-risk patients with diffuse large B-cell lymphomas S Cortelazzo, C Tarella, AM Gianni, M Ladetto, AM Barbui, A Rossi, ... Journal of Clinical Oncology 34 (33), 4015-4022, 2016 | 86 | 2016 |
| Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target MR Sapienza, F Abate, F Melle, S Orecchioni, F Fuligni, M Etebari, ... haematologica 104 (4), 729, 2019 | 71 | 2019 |
| Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases F Facchetti, SA Pileri, L Lorenzi, V Tabanelli, L Rimsza, S Pittaluga, ... Virchows Archiv 471, 467-489, 2017 | 66 | 2017 |
| CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? F Zaja, V Tabanelli, C Agostinelli, A Calleri, A Chiappella, M Varettoni, ... American journal of hematology 92 (1), E1-E2, 2017 | 43 | 2017 |
| Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified MA Laginestra, L Cascione, G Motta, F Fuligni, C Agostinelli, M Rossi, ... Modern Pathology 33 (2), 179-187, 2020 | 42 | 2020 |
| Molecular genetics of peripheral T-cell lymphomas PP Piccaluga, V Tabanelli, SA Pileri International journal of hematology 99, 219-226, 2014 | 41 | 2014 |
| Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified MA Laginestra, PP Piccaluga, F Fuligni, M Rossi, C Agostinelli, S Righi, ... Blood Cancer Journal 4 (11), e259-e259, 2014 | 35 | 2014 |
| Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant–associated anaplastic large cell lymphomas V Tabanelli, C Corsini, S Fiori, C Agostinelli, A Calleri, S Orecchioni, ... Human Pathology 90, 60-69, 2019 | 30 | 2019 |
| Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of follicular dendritic cell sarcomas MA Laginestra, C Tripodo, C Agostinelli, G Motta, S Hartmann, C Döring, ... Molecular cancer research 15 (5), 541-552, 2017 | 30 | 2017 |
| Gene expression signatures for the accurate diagnosis of peripheral T-cell lymphoma entities in the routine clinical practice C Amador, A Bouska, G Wright, DD Weisenburger, AL Feldman, ... Journal of clinical oncology 40 (36), 4261, 2022 | 21 | 2022 |
| Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: a case report and review of the literature V Tabanelli, C Agostinelli, E Sabattini, A Gazzola, F Bacci, S Capria, ... Journal of Medical Case Reports 5, 1-5, 2011 | 19 | 2011 |
| Complete and long‐lasting cytologic and molecular remission of FIP1L1‐PDGFRA‐positive acute eosinophil myeloid leukaemia, treated with low‐dose imatinib … D Barraco, F Carobolante, A Candoni, E Simeone, P Piccaluga, ... European Journal of Haematology 92 (6), 541-545, 2014 | 17 | 2014 |
| Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma A Rossi, S Orecchioni, P Falvo, V Tabanelli, E Baiardi, C Agostinelli, ... Leukemia 36 (1), 197-209, 2022 | 14 | 2022 |
| Definition and validation of the new elderly prognostic index (EPI) for elderly patients with diffuse large B-cell lymphoma integrating geriatric and clinical assessment … M Spina, F Merli, B Puccini, F Cavallo, MG Cabras, A Fabbri, F Angrilli, ... Blood 134, 398, 2019 | 12 | 2019 |
| Peripheral T-cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment SA Pileri, V Tabanelli, S Fiori, A Calleri, F Melle, G Motta, D Lorenzini, ... Cancers 13 (18), 4535, 2021 | 11 | 2021 |
| Predictive and prognostic molecular factors in diffuse large B-cell lymphomas SA Pileri, C Tripodo, F Melle, G Motta, V Tabanelli, S Fiori, MC Vegliante, ... Cells 10 (3), 675, 2021 | 11 | 2021 |
| A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma E Derenzini, S Mazzara, F Melle, G Motta, M Fabbri, R Bruna, ... Haematologica 106 (9), 2405, 2021 | 10 | 2021 |
